Caitlin Thomas Ravichandran, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angelman Syndrome | 2 | 2021 | 139 | 0.800 |
Why?
|
Bipolar Disorder | 12 | 2019 | 5131 | 0.550 |
Why?
|
Williams Syndrome | 3 | 2024 | 195 | 0.540 |
Why?
|
Psychotic Disorders | 7 | 2024 | 3278 | 0.460 |
Why?
|
Phosphocreatine | 5 | 2016 | 261 | 0.420 |
Why?
|
Periodicals as Topic | 1 | 2022 | 1470 | 0.380 |
Why?
|
Schizophrenic Psychology | 3 | 2017 | 1651 | 0.370 |
Why?
|
Functional Laterality | 2 | 2017 | 2267 | 0.360 |
Why?
|
Psychiatry | 1 | 2022 | 1716 | 0.350 |
Why?
|
Dietetics | 1 | 2008 | 34 | 0.310 |
Why?
|
Schizophrenia | 5 | 2018 | 6987 | 0.290 |
Why?
|
Energy Metabolism | 7 | 2019 | 2905 | 0.250 |
Why?
|
Magnetic Resonance Spectroscopy | 10 | 2016 | 3782 | 0.250 |
Why?
|
Hallucinations | 2 | 2018 | 375 | 0.210 |
Why?
|
Brain | 13 | 2023 | 27453 | 0.200 |
Why?
|
Phosphates | 2 | 2016 | 765 | 0.200 |
Why?
|
Psychiatric Status Rating Scales | 7 | 2024 | 6030 | 0.200 |
Why?
|
Ubiquinone | 2 | 2015 | 183 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8617 | 0.200 |
Why?
|
Autistic Disorder | 4 | 2013 | 1240 | 0.190 |
Why?
|
Creatine Kinase | 2 | 2015 | 684 | 0.190 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2714 | 0.190 |
Why?
|
Anti-Anxiety Agents | 1 | 2024 | 405 | 0.190 |
Why?
|
Publishing | 1 | 2008 | 837 | 0.180 |
Why?
|
Analysis of Variance | 2 | 2008 | 6236 | 0.180 |
Why?
|
Adenosine Triphosphate | 3 | 2016 | 2003 | 0.180 |
Why?
|
Tics | 1 | 2021 | 76 | 0.180 |
Why?
|
Catatonia | 1 | 2023 | 181 | 0.170 |
Why?
|
Publications | 1 | 2022 | 195 | 0.170 |
Why?
|
Dissociative Disorders | 1 | 2022 | 235 | 0.170 |
Why?
|
Clozapine | 1 | 2023 | 509 | 0.170 |
Why?
|
Personality Disorders | 1 | 2024 | 729 | 0.170 |
Why?
|
Aspartic Acid | 2 | 2019 | 577 | 0.150 |
Why?
|
Depressive Disorder, Major | 5 | 2016 | 4818 | 0.150 |
Why?
|
Olfactory Perception | 1 | 2018 | 65 | 0.140 |
Why?
|
Psychomotor Agitation | 1 | 2020 | 307 | 0.140 |
Why?
|
Antidepressive Agents | 3 | 2015 | 2913 | 0.140 |
Why?
|
Touch Perception | 1 | 2018 | 106 | 0.130 |
Why?
|
Aging | 5 | 2019 | 8745 | 0.130 |
Why?
|
Delusions | 1 | 2018 | 301 | 0.130 |
Why?
|
Down Syndrome | 1 | 2024 | 919 | 0.120 |
Why?
|
Young Adult | 19 | 2024 | 60131 | 0.120 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2024 | 4640 | 0.120 |
Why?
|
Affect | 2 | 2013 | 1500 | 0.120 |
Why?
|
Humans | 55 | 2024 | 768970 | 0.120 |
Why?
|
Leadership | 1 | 2024 | 1396 | 0.120 |
Why?
|
Double-Blind Method | 9 | 2024 | 12467 | 0.120 |
Why?
|
Microglia | 1 | 2023 | 1376 | 0.120 |
Why?
|
Oligodendroglia | 1 | 2018 | 540 | 0.120 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2010 | 953 | 0.120 |
Why?
|
Male | 41 | 2024 | 365203 | 0.110 |
Why?
|
Temporal Lobe | 2 | 2013 | 1728 | 0.110 |
Why?
|
Models, Statistical | 1 | 2008 | 5110 | 0.110 |
Why?
|
Anxiety | 4 | 2024 | 4672 | 0.110 |
Why?
|
Magnetic Field Therapy | 1 | 2013 | 27 | 0.110 |
Why?
|
Adult | 28 | 2024 | 223851 | 0.110 |
Why?
|
Longitudinal Studies | 2 | 2011 | 14794 | 0.110 |
Why?
|
Female | 37 | 2024 | 397515 | 0.100 |
Why?
|
S-Adenosylmethionine | 1 | 2014 | 219 | 0.100 |
Why?
|
Cytidine | 1 | 2012 | 60 | 0.100 |
Why?
|
Depressive Disorder | 2 | 2016 | 3723 | 0.100 |
Why?
|
Research Design | 1 | 2008 | 6214 | 0.100 |
Why?
|
Naltrexone | 1 | 2014 | 319 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2024 | 4056 | 0.100 |
Why?
|
Organophosphorus Compounds | 1 | 2013 | 211 | 0.100 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2021 | 1508 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 10400 | 0.090 |
Why?
|
Anxiety Disorders | 3 | 2024 | 2749 | 0.090 |
Why?
|
Cytidine Diphosphate Choline | 1 | 2011 | 29 | 0.090 |
Why?
|
Child | 12 | 2024 | 80960 | 0.090 |
Why?
|
Overweight | 1 | 2022 | 2448 | 0.090 |
Why?
|
Garbage | 1 | 2009 | 4 | 0.090 |
Why?
|
Glutamic Acid | 2 | 2019 | 1191 | 0.090 |
Why?
|
Refuse Disposal | 1 | 2009 | 31 | 0.090 |
Why?
|
Waste Management | 1 | 2009 | 19 | 0.080 |
Why?
|
Nootropic Agents | 1 | 2011 | 159 | 0.080 |
Why?
|
Narcotic Antagonists | 1 | 2014 | 591 | 0.080 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 4 | 2024 | 1988 | 0.080 |
Why?
|
Diffusion Tensor Imaging | 2 | 2010 | 2426 | 0.080 |
Why?
|
Communication | 1 | 2023 | 3908 | 0.080 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5831 | 0.080 |
Why?
|
Caregivers | 1 | 2021 | 2308 | 0.080 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 3730 | 0.080 |
Why?
|
Sertraline | 1 | 2009 | 209 | 0.070 |
Why?
|
Middle Aged | 25 | 2024 | 223737 | 0.070 |
Why?
|
Sleep Deprivation | 1 | 2014 | 848 | 0.070 |
Why?
|
Cocaine-Related Disorders | 1 | 2011 | 458 | 0.070 |
Why?
|
Parents | 1 | 2021 | 3597 | 0.070 |
Why?
|
Executive Function | 1 | 2016 | 1405 | 0.070 |
Why?
|
Phosphorus Isotopes | 3 | 2013 | 125 | 0.070 |
Why?
|
Cities | 1 | 2009 | 543 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2258 | 0.070 |
Why?
|
Marijuana Abuse | 1 | 2011 | 409 | 0.070 |
Why?
|
Adolescent | 14 | 2024 | 89244 | 0.070 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2018 | 1891 | 0.070 |
Why?
|
Sleep | 2 | 2020 | 4820 | 0.070 |
Why?
|
Pilot Projects | 4 | 2024 | 8748 | 0.070 |
Why?
|
Phospholipids | 1 | 2010 | 787 | 0.070 |
Why?
|
Antipsychotic Agents | 1 | 2019 | 3081 | 0.060 |
Why?
|
Altitude | 1 | 2006 | 163 | 0.060 |
Why?
|
Prevalence | 1 | 2022 | 15879 | 0.060 |
Why?
|
Sickness Impact Profile | 1 | 2006 | 299 | 0.060 |
Why?
|
Evoked Potentials | 1 | 2011 | 1058 | 0.060 |
Why?
|
Angola | 1 | 2024 | 18 | 0.060 |
Why?
|
Brain Mapping | 4 | 2013 | 6739 | 0.060 |
Why?
|
Benzodiazepines | 1 | 2010 | 1138 | 0.060 |
Why?
|
Narcissism | 1 | 2024 | 64 | 0.060 |
Why?
|
Gonadal Hormones | 1 | 2023 | 29 | 0.060 |
Why?
|
Guanfacine | 1 | 2024 | 50 | 0.060 |
Why?
|
Suicide, Attempted | 1 | 2013 | 1409 | 0.060 |
Why?
|
Cell Membrane | 1 | 2013 | 3659 | 0.050 |
Why?
|
Buspirone | 1 | 2024 | 80 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2024 | 81903 | 0.050 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2013 | 1106 | 0.050 |
Why?
|
Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2024 | 108 | 0.050 |
Why?
|
Creatine | 2 | 2019 | 427 | 0.050 |
Why?
|
Central Nervous System | 1 | 2010 | 1346 | 0.050 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2012 | 1399 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 15661 | 0.050 |
Why?
|
Lorazepam | 1 | 2023 | 155 | 0.050 |
Why?
|
Hypnotics and Sedatives | 1 | 2010 | 1191 | 0.050 |
Why?
|
Neural Pathways | 2 | 2011 | 3120 | 0.050 |
Why?
|
Glutamine | 2 | 2019 | 578 | 0.050 |
Why?
|
Entorhinal Cortex | 1 | 2024 | 288 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 15471 | 0.050 |
Why?
|
Linear Models | 2 | 2010 | 5891 | 0.050 |
Why?
|
Neurites | 1 | 2024 | 390 | 0.050 |
Why?
|
Hospitalization | 2 | 2020 | 10847 | 0.050 |
Why?
|
Factor Analysis, Statistical | 1 | 2024 | 1002 | 0.050 |
Why?
|
Suicide | 1 | 2013 | 1606 | 0.050 |
Why?
|
Obsessive Behavior | 1 | 2021 | 51 | 0.050 |
Why?
|
Nausea | 1 | 2024 | 682 | 0.050 |
Why?
|
Trazodone | 1 | 2020 | 67 | 0.040 |
Why?
|
Models, Psychological | 1 | 2024 | 826 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 2024 | 969 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15951 | 0.040 |
Why?
|
Obesity | 1 | 2022 | 13091 | 0.040 |
Why?
|
Policy | 1 | 2023 | 514 | 0.040 |
Why?
|
Clonidine | 1 | 2020 | 170 | 0.040 |
Why?
|
Treatment Outcome | 6 | 2024 | 65480 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2018 | 36854 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2016 | 22296 | 0.040 |
Why?
|
Lung Diseases | 1 | 2008 | 1944 | 0.040 |
Why?
|
Psoriasis | 1 | 2006 | 926 | 0.040 |
Why?
|
Aged | 13 | 2019 | 171786 | 0.040 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2024 | 862 | 0.030 |
Why?
|
Marital Status | 1 | 2018 | 426 | 0.030 |
Why?
|
Amygdala | 1 | 2024 | 1379 | 0.030 |
Why?
|
Comorbidity | 3 | 2019 | 10592 | 0.030 |
Why?
|
Phosphorus | 1 | 2016 | 336 | 0.030 |
Why?
|
Psychotherapy | 1 | 2024 | 1654 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 2488 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14752 | 0.030 |
Why?
|
Melatonin | 1 | 2020 | 670 | 0.030 |
Why?
|
Myelin Sheath | 1 | 2018 | 653 | 0.030 |
Why?
|
Oxygen | 1 | 2006 | 4272 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 800 | 0.030 |
Why?
|
Child, Preschool | 4 | 2022 | 42683 | 0.030 |
Why?
|
Glycerylphosphorylcholine | 1 | 2013 | 25 | 0.030 |
Why?
|
Phosphatidylethanolamines | 1 | 2013 | 131 | 0.030 |
Why?
|
Ethanolamines | 1 | 2013 | 152 | 0.030 |
Why?
|
Phosphorylcholine | 1 | 2013 | 153 | 0.030 |
Why?
|
Nucleotides | 1 | 2014 | 455 | 0.020 |
Why?
|
Electromagnetic Fields | 1 | 2013 | 289 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2024 | 10765 | 0.020 |
Why?
|
Smoking | 1 | 2008 | 9094 | 0.020 |
Why?
|
India | 2 | 2009 | 2334 | 0.020 |
Why?
|
Alprazolam | 1 | 2010 | 103 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2013 | 9080 | 0.020 |
Why?
|
Clonazepam | 1 | 2010 | 135 | 0.020 |
Why?
|
Curriculum | 1 | 2024 | 3782 | 0.020 |
Why?
|
GABA Modulators | 1 | 2010 | 109 | 0.020 |
Why?
|
Health Personnel | 1 | 2024 | 3383 | 0.020 |
Why?
|
Educational Status | 1 | 2018 | 2515 | 0.020 |
Why?
|
Emotions | 1 | 2022 | 2768 | 0.020 |
Why?
|
Mitochondria | 1 | 2023 | 3682 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3928 | 0.020 |
Why?
|
Psychometrics | 2 | 2012 | 3066 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2012 | 810 | 0.020 |
Why?
|
Panic Disorder | 1 | 2012 | 613 | 0.020 |
Why?
|
Choline | 1 | 2010 | 522 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2015 | 2003 | 0.020 |
Why?
|
Acoustic Stimulation | 1 | 2013 | 1256 | 0.020 |
Why?
|
Substance Abuse Detection | 1 | 2011 | 301 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39394 | 0.020 |
Why?
|
Organ Size | 1 | 2013 | 2268 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3773 | 0.020 |
Why?
|
Psychotherapy, Group | 1 | 2011 | 417 | 0.020 |
Why?
|
Anisotropy | 1 | 2010 | 1295 | 0.020 |
Why?
|
Heart Rate | 2 | 2011 | 4217 | 0.020 |
Why?
|
Internet | 1 | 2019 | 3112 | 0.020 |
Why?
|
Education | 1 | 2009 | 533 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18435 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2862 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2664 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 4040 | 0.020 |
Why?
|
Polysomnography | 1 | 2013 | 1871 | 0.020 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2011 | 628 | 0.020 |
Why?
|
Cues | 1 | 2011 | 878 | 0.020 |
Why?
|
Mitochondrial Diseases | 1 | 2009 | 344 | 0.020 |
Why?
|
Protons | 1 | 2010 | 1113 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54962 | 0.010 |
Why?
|
Cell Line | 1 | 2018 | 15604 | 0.010 |
Why?
|
Quality of Life | 1 | 2006 | 13510 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2108 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2010 | 1141 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2016 | 59739 | 0.010 |
Why?
|
Homeostasis | 1 | 2014 | 3347 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2012 | 20245 | 0.010 |
Why?
|
Oximetry | 1 | 2006 | 462 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7148 | 0.010 |
Why?
|
Suicidal Ideation | 1 | 2013 | 1462 | 0.010 |
Why?
|
Primary Health Care | 1 | 2019 | 4748 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6320 | 0.010 |
Why?
|
Animals | 2 | 2024 | 169335 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4879 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 30265 | 0.010 |
Why?
|
Language | 1 | 2010 | 1559 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2018 | 11684 | 0.010 |
Why?
|
Attention | 1 | 2011 | 2423 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 74976 | 0.010 |
Why?
|
Respiration | 1 | 2006 | 1668 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10868 | 0.010 |
Why?
|
Depression | 1 | 2019 | 8231 | 0.010 |
Why?
|
Electroencephalography | 1 | 2014 | 6317 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8559 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4940 | 0.010 |
Why?
|
Time Factors | 2 | 2010 | 40261 | 0.010 |
Why?
|
Mice | 1 | 2023 | 82072 | 0.010 |
Why?
|
Regression Analysis | 1 | 2006 | 6346 | 0.010 |
Why?
|
United States | 1 | 2024 | 73186 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26395 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9384 | 0.010 |
Why?
|
Prognosis | 1 | 2011 | 30046 | 0.010 |
Why?
|
Infant | 1 | 2006 | 36556 | 0.000 |
Why?
|